Related Experiment Video
Updated: Jul 20, 2025

08:37
Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
3.7K
The future of brain circuit-targeted therapeutics
Shan H Siddiqi1,2, Sanaz Khosravani3,4, John D Rolston3,5
1Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Boston, MA, USA. shsiddiqi@bwh.harvard.edu.
Summary
This study proposes a three-phase framework for selecting brain circuit targets for neuromodulation therapies like TMS and DBS. This approach aims to improve treatment of neuropsychiatric disorders by optimizing target identification and stimulation methods.
Area of Science:
- Neuroscience
- Neuromodulation
- Brain Circuit Therapeutics
Background:
- Brain stimulation techniques like transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and focused ultrasound (FUS) are increasingly used for neuropsychiatric disorders.
- Effective treatment relies on precise targeting of specific brain circuits.
- Current methods for target identification and modulation require a structured framework.
Purpose of the Study:
- To propose a comprehensive three-phase framework for identifying and modulating brain circuit targets for neuromodulation therapies.
- To guide the selection of appropriate stimulation targets and modalities for treating neuropsychiatric conditions.
Main Methods:
- Phase 1: Target identification using correlative neuroimaging, retrospective optimization, and lesion localization.
- Phase 2: Target optimization via personalized neuroimaging, physiological monitoring, and state engagement (pharmacological/psychological).
- Phase 3: Modality selection considering the advantages and tradeoffs of different brain stimulation techniques.
Main Results:
- The proposed framework integrates multiple approaches for target identification and optimization.
- It provides a systematic method for choosing the most suitable stimulation modality or combination.
- Preliminary literature supports various components of the framework, indicating its potential clinical utility.
Conclusions:
- The framework offers a structured approach to advancing brain circuit therapeutics.
- Further research is needed to address unanswered questions and refine the framework.
- This work presents opportunities for future growth in research and clinical applications of neuromodulation.
Related Concept Videos
Brain Imaging
258
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
258
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

